1064P Final results of CA209-9JC: A phase II study of first-line nivolumab in patients with advanced cutaneous squamous cell carcinoma

This article has no abstract
Epistemonikos ID: 1adc1c103d53c8aedd033ac70e0831a84ab822d8
First added on: Feb 13, 2025